ChartRow logo
Share this page

INCY financial statements

The full income statement, balance sheet, and cash-flow statement for Incyte Corp. (INCY), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Financial overview#

Revenue

5Y CAGR +14.0%10Y CAGR +21.2%YoY +14.0%
$6B TTM$1.6B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q3 '16Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Gross profit

5Y CAGR +13.5%10Y CAGR +20.7%YoY +14.3%
$5.6B TTM$1.4B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q3 '16Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y n/m10Y CAGR +40.5%YoY n/m
$626.5M TTM−$708.4M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q3 '16Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

5Y n/m10Y CAGR +69.6%YoY n/m
$403.4M TTM−$784.8M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q3 '16Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y n/m10Y CAGR +71.0%YoY n/m
$1.96 TTM−$3.86 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q3 '16Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating cash flow

5Y n/m10Y CAGR +31.8%YoY n/m
$745M TTM−$675.3M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q3 '16Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Capital expenditure

5Y CAGR −20.7%10Y CAGR +8.5%YoY +6.0%
$60.1M TTM$15.6M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q3 '16Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y n/m10Y CAGR +35.8%YoY n/m
$684.9M TTM−$691M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q3 '16Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Shares (diluted)

5Y −8.0%10Y +7.2%YoY +0.9%
205.7M TTM203.2M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q3 '16Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Shares outstanding (point-in-time)

2024-09 192.7M2024-12 193.5M2025-03 193.6M2025-06 195.3M2025-09 196.3M2025-12 199.0M2026-03 199.8M2026-06 202.7M2026-09 203.8M+5.8% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue5.14B+21.2%4.24B+14.8%3.70B+8.9%3.39B+13.7%2.99B+12.0%
4.77B+21.4%3.93B+14.2%3.44B+7.9%3.19B+12.4%2.84B+11.8%
Cost of revenue372M+19.2%312M+22.4%255M+23.2%207M+37.1%151M+15.0%
Research & development2.05B-21.4%2.61B+60.2%1.63B+2.6%1.59B+8.8%1.46B-34.2%
Selling, general & administrative1.38B+10.8%1.24B+7.5%1.16B+15.3%1.00B+35.5%740M+43.1%
Amortization of intangibles26.7M+13.1%23.6M+4.9%22.5M+4.7%21.5M+0.0%21.5M+0.0%
Operating income1.51B+2368.6%61.4M-90.1%621M+7.1%579M-1.1%586M+322.2%
Interest expense2.43M+6.5%2.28M-10.6%2.55M-4.3%2.67M+39.7%1.91M-12.2%
Interest & investment income106M-18.0%129M-18.8%158M+291.6%40.5M—
Other non-operating income25.1M+96.0%12.8M-8.1%13.9M+2784.8%-519K-104.9%10.6M-54.1%
Gain (loss) on equity securities21.3M-81.6%116M+164.3%43.9M+150.1%-87.6M-263.9%-24.1M-330.9%
Pre-tax income1.66B+425.7%317M-62.0%834M+57.7%529M-7.2%570M+345.7%
Income tax378M+33.0%284M+20.0%237M+25.6%188M+149.8%-378M-695.7%
1.29B+3845.0%32.6M-94.5%598M+75.4%341M-64.1%949M+420.8%
Net income to common1.29B+3845.0%32.6M-94.5%598M+75.4%341M-64.1%949M+420.8%
$6.41+4173.3%$0.15-94.3%$2.65+74.3%$1.52-64.4%$4.27+414.0%
EPS (basic)$6.59+4018.8%$0.16-94.0%$2.67+74.5%$1.53-64.4%$4.30+416.2%
Weighted-avg shares (basic)195M-5.7%207M-7.4%224M+0.7%222M+0.7%220M+1.1%
Weighted-avg shares (diluted)201M-4.7%211M-6.8%226M+0.9%224M+0.8%222M+1.8%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
5.02B+55.1%3.24B-30.3%4.65B+13.5%4.09B+31.2%3.12B+32.2%
Cash & equivalents3.10B+83.5%1.69B-47.5%3.21B+8.9%2.95B+43.5%2.06B+36.0%
Inventory101M+71.7%58.9M-6.5%63.0M+50.0%42.0M+50.5%27.9M+69.9%
Prepaid expenses318M+88.2%169M-7.6%183M+9.5%167M+32.3%126M+110.1%
6.96B+27.8%5.44B-19.7%6.78B+16.1%5.84B+18.4%4.93B+38.5%
Property, plant & equipment731M-4.3%763M+1.6%752M+1.7%739M+2.1%724M+29.4%
Goodwill133M-14.5%156M+0.0%156M+0.0%156M+0.0%156M+0.0%
Long-term investments——188M+40.4%134M-39.6%221M-0.5%
Deferred tax assets515M-32.4%762M+20.6%632M+38.0%458M-2.1%468M+22662.3%
Other non-current assets18.2M+67.5%10.8M-79.2%52.1M+104.9%25.4M-31.8%37.3M-5.3%
1.52B-7.7%1.64B+32.4%1.24B+7.2%1.16B+35.4%854M+35.3%
Accounts payable210M+6.3%197M+80.2%110M-60.5%278M+61.3%172M+74.3%
Accrued liabilities1.03B-14.9%1.21B+29.6%936M+33.5%701M+31.4%534M+41.0%
Current lease liability5.70M+2.0%5.58M-1.8%5.69M-30.6%8.20M-22.4%10.6M-16.7%
Other current liabilities90.7M+54.1%58.9M-19.7%73.3M+7.2%68.4M+49.6%45.8M+30.3%
Finance lease liability (current)4.52M+2.2%4.42M+28.5%3.44M+8.2%3.18M+20.6%2.63M+15.4%
1.79B-10.3%2.00B+25.4%1.59B+8.3%1.47B+26.4%1.16B+22.5%
Non-current lease liability14.5M-13.6%16.8M+17.6%14.3M+1.2%14.1M-9.6%15.6M+10.0%
Operating lease liability (total)20.2M-9.7%22.4M+12.0%20.0M-10.5%22.3M-14.7%26.2M-2.6%
Finance lease liability (total)34.7M-8.6%38.0M+16.4%32.6M-2.0%33.3M-2.9%34.3M-1.7%
Finance lease liability30.2M-10.0%33.5M+15.0%29.2M-3.1%30.1M-4.9%31.6M-2.9%
Other non-current liabilities165M-1.4%168M+12.3%149M+50.3%99.2M+40.9%70.4M+20.8%
5.17B+49.9%3.45B-33.6%5.19B+18.8%4.37B+15.9%3.77B+44.4%
Preferred stock0.000.000.000.000.00
Common stock198K+2.6%193K-13.8%224K+0.4%223K+0.9%221K+0.9%
Additional paid-in capital4.93B+8.7%4.53B-9.6%5.02B+4.7%4.79B+4.9%4.57B+4.9%
Retained earnings214M+119.9%-1.07B-768.9%160M+136.7%-437M+43.8%-778M+54.9%
Accumulated other comprehensive income25.5M+294.1%-13.1M-200.1%13.1M-13.0%15.1M+177.5%-19.5M-26.7%
Total equity incl. non-controlling5.17B+49.9%3.45B-33.6%5.19B+18.8%4.37B+15.9%3.77B+44.4%
Total liabilities & equity6.96B+27.8%5.44B-19.7%6.78B+16.1%5.84B+18.4%4.93B+38.5%
Common shares issued198M+2.6%193M-13.8%224M+0.7%223M+0.8%221M+0.7%
Common shares outstanding198M+2.6%193M-13.8%224M+0.7%223M+0.8%221M+0.7%
Shares outstanding (cover)199M+2.8%194M-13.8%225M+0.7%223M+0.7%221M+0.7%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
1.41B+321.5%335M-32.5%496M-48.8%970M+29.4%749M+701.5%
Depreciation & amortization93.3M+4.5%89.2M+8.0%82.7M+21.8%67.9M+17.3%57.8M+11.7%
Intangible amortization26.7M+13.1%23.6M+4.9%22.5M+4.7%21.5M+0.0%21.5M+0.0%
Share-based compensation249M-6.3%266M+23.2%216M+14.6%188M+3.0%183M+2.9%
Deferred income taxes248M+389.5%-85.6M+46.2%-159M-378.3%57.1M+112.3%-466M-132929.7%
Change in receivables171M+53.0%112M+13.1%98.7M+245.3%28.6M-78.7%134M-22.4%
Change in inventory58.5M-54.2%128M-25.0%170M+152.1%67.5M+222.0%21.0M+7.7%
Change in payables6.56M-92.6%88.2M+152.5%-168M-259.3%105M+43.8%73.3M+385.1%
-103M-165.1%158M+175.8%-208M-164.4%-78.5M+62.2%-208M+22.8%
Capital expenditure58.9M-31.8%86.3M+165.5%32.5M-58.3%77.8M-57.0%181M-3.4%
Free cash flow1.35B+443.9%249M-46.3%464M-48.0%892M+56.9%568M+282.2%
Acquisitions0.000.000.000.000.00
101M+105.0%-2.02B-9991.1%-20.0M-2423.0%-794K-112.9%6.18M-91.4%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.000.000.000.000.00
Common stock repurchased0.00-100.0%2.00B0.000.000.00
Dividends paid0.000.000.000.000.00
FX effect on cash-1.71M-158.5%2.92M+143.8%-6.68M-299.0%3.35M+194.0%-3.57M-221.1%
Net change in cash1.41B+192.4%-1.53B-682.1%262M-70.7%894M+64.2%544M+270.7%
Interest paid
————396K+104.1%
Income taxes paid212M-43.1%373M-1.4%378M+177.6%136M+101.2%67.7M-4.2%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap19.6B+46.7%13.4B-5.1%14.1B-21.3%17.9B+10.1%16.2B-15.0%
P/E15.2×-96.3%409.6×+1137.2%33.1×+62.3%20.4×+19.2%17.1×
P/S3.8×+21.0%3.2×-19.2%3.9×-27.3%5.4×-1.3%5.4×-24.1%
P/B3.8×-2.1%3.9×+35.8%2.9×-32.5%4.2×-1.8%4.3×-41.1%
P/FCF14.5×-73.0%53.6×+121.4%24.2×-3.7%25.1×-11.9%28.5×
Earnings yield6.6%+2588.9%0.24%-91.9%3.0%-38.4%4.9%-16.1%5.8%
FCF yield6.9%+270.7%1.9%-54.8%4.1%+3.8%4.0%+13.5%3.5%
Source filing10-K10-K10-K10-K10-K

About this data

Source: INCY’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all INCY filings on SEC EDGAR → Not investment advice.